openPR Logo
Press release

Leading Companies Consolidating Their Presence in the Structural Heart Market

04-06-2026 07:07 AM CET | Health & Medicine

Press release from: The Business Research Company

Structural Heart Market

Structural Heart Market

The structural heart market is on a promising growth trajectory, driven by technological advancements and rising demand for less invasive cardiac procedures. Increasing investments and innovations in this sector are set to reshape treatment options for patients worldwide, making this an exciting area to watch in healthcare.

Projected Market Growth and Size of the Structural Heart Market
The structural heart market is predicted to experience substantial expansion, reaching a valuation of $24.6 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 9.2%. Several factors contribute to this upward trend, including a growing preference for transcatheter therapies, significant investments in structural heart programs, and the development of specialized cardiac centers of excellence. Additionally, advances in device miniaturization and a greater focus on reducing the number of invasive open-heart surgeries are encouraging market growth. Key trends shaping the future include wider adoption of transcatheter valve procedures, increased use of minimally invasive interventions, integration of advanced cardiac imaging, growth in catheter-based repair technologies, and personalized treatment planning for patients.

Download a free sample of the structural heart market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Top Companies Influencing the Structural Heart Market
The structural heart market landscape is dominated by several well-established players, such as Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q'Apel Medical Inc., and Z-Medical GmbH + Co. KG.

In a significant move in July 2024, Edwards Lifesciences, a US-based leader in structural heart disease therapies and critical care technologies, acquired JenaValve Technology and Endotronix for around $1.2 billion. This acquisition is aimed at broadening Edwards' portfolio by entering new treatment areas, bolstering its innovation capabilities, and targeting unmet clinical needs in aortic regurgitation and heart failure. JenaValve Technology, based in Germany, specializes in transcatheter aortic valve replacement solutions for aortic regurgitation, while Endotronix, headquartered in the US, provides implantable hemodynamic monitoring systems and digital heart failure management platforms.

View the full structural heart market report:
https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Emerging Developments and Innovations in the Structural Heart Market
Leading companies in the structural heart arena are focusing on developing advanced devices to enhance minimally invasive treatments. One such innovation is the transcatheter edge-to-edge repair (TEER) system, designed for treating heart valve diseases like mitral valve regurgitation. For example, in April 2024, Abbott Laboratories received approval from the US Food and Drug Administration (FDA) for its TriClip device. TriClip is a minimally invasive TEER system that is inserted through a vein in the leg, offering a valve repair option without the need for open-heart surgery. This makes it particularly beneficial for patients who are older or have other health risks. The device functions by clipping and drawing together the leaflets of the tricuspid valve, which reduces regurgitation and improves blood circulation.

Key Segments Driving the Structural Heart Market Growth
This report segments the structural heart market into several categories:
1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, and Other Products
2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure
3) By End Users: Hospitals and Cardiac Centers

Further subcategories are:
- Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders
- Annuloplasty Rings: Rigid, Flexible, and Adjustable Annuloplasty Rings
- Heart Valve Balloons: Balloon Expandable Heart Valve Systems and Valvuloplasty Balloons
- Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, and Delivery Systems for Structural Heart Procedures

This segmentation highlights the diverse range of products and procedures contributing to the ongoing growth and innovation within the structural heart market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leading Companies Consolidating Their Presence in the Structural Heart Market here

News-ID: 4455413 • Views:

More Releases from The Business Research Company

Global Factors Shaping the Rapid Evolution of the Temperature Management Market
Global Factors Shaping the Rapid Evolution of the Temperature Management Market
The temperature management market is gaining substantial momentum and is set to witness significant growth in the coming years. Driven by advancements across healthcare sectors and evolving clinical needs, this market is becoming increasingly vital in critical care and surgical environments. Let's explore the market's projected size, leading companies, emerging trends, and key segments shaping its future. Forecasted Growth and Market Size for Temperature Management The temperature management market is anticipated to
In-Depth Examination of Segments, Industry Trends, and Key Players in the Synthetic Blood Substitutes and Blood Products Market
In-Depth Examination of Segments, Industry Trends, and Key Players in the Synthe …
The synthetic blood substitutes and blood products industry is positioned for substantial growth in the coming years, driven by advancements in medical technology and rising healthcare demands. This market's evolution reflects significant progress in addressing critical needs such as trauma care and blood shortages, setting the stage for a promising future. Projected Expansion and Market Size of Synthetic Blood Substitutes and Blood Products The synthetic blood substitutes and blood products market is
Leading Companies Fueling Growth and Innovation in the Surgical Sponge Market
Leading Companies Fueling Growth and Innovation in the Surgical Sponge Market
The surgical sponge market is positioned for substantial expansion over the coming years, driven by advancements in surgical techniques and increasing emphasis on patient safety. As healthcare practices evolve, the demand for effective and reliable surgical sponges is expected to rise, opening new avenues for innovation and growth within this sector. Projected Market Size and Growth Trajectory of the Surgical Sponge Market The surgical sponge market is anticipated to reach a value
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Tibial Bearings Market
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the T …
The tibial bearings market is on the verge of significant expansion, driven by advancements in medical technology and increasing demand for improved knee implant solutions. This sector is attracting considerable attention as innovations and rising healthcare needs combine to fuel its upward trajectory. Let's explore how the market size is expected to evolve, what's driving growth, the key players involved, and the latest trends shaping this industry. Projected Growth and Market

All 5 Releases


More Releases for Heart

Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health. Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease. Top Heart Healthy Foods Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after